3,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice
- 15 September 2007
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 62 (6), 669-679
- https://doi.org/10.1016/j.biopsych.2006.11.005
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Effect of 3,4-methylendioxymethamphetamine (MDMA, “ecstasy”) on dopamine transmission in the nucleus accumbens shell and coreBrain Research, 2005
- 5‐HT2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulantsEuropean Journal of Neuroscience, 2004
- Serotonin–GABA interactions modulate MDMA‐induced mesolimbic dopamine releaseJournal of Neurochemistry, 2004
- Role of serotonin2A receptors in the d‐amphetamine‐induced release of dopamine: comparison with previous data on α1b‐adrenergic receptorsJournal of Neurochemistry, 2004
- Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivoEuropean Journal of Pharmacology, 2001
- Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient MiceMolecular Pharmacology, 1998
- CGS 10746B, a Novel Dopamine Release Inhibitor, Blocks the Establishment of Cocaine and MDMA Conditioned Place PreferencesPharmacology Biochemistry and Behavior, 1998
- MDMA produces a conditioned place preference and elicits ejaculation in male rats: A modulatory role for the endogenous opioidsPharmacology Biochemistry and Behavior, 1991
- MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preferencePharmacology Biochemistry and Behavior, 1991
- Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeysDrug and Alcohol Dependence, 1986